Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 170

1.

Factors predictive of the presence of a CSF1R mutation in patients with leukoencephalopathy.

Kondo Y, Matsushima A, Nagasaki S, Nakamura K, Sekijima Y, Yoshida K.

Eur J Neurol. 2019 Sep 14. doi: 10.1111/ene.14086. [Epub ahead of print]

PMID:
31520500
2.

Familial Mediterranean Fever is Important in the Differential Diagnosis of Recurrent Aseptic Meningitis in Japan.

Hosoi T, Ishii K, Tozaka N, Kishida D, Sekijima Y, Tamaoka A.

Intern Med. 2019 Sep 11. doi: 10.2169/internalmedicine.3432-19. [Epub ahead of print]

3.

Acquired Amegakaryocytic Thrombocytopenia in Adult-onset Still's Disease: Successful Combination Therapy with Tocilizumab and Cyclosporine.

Ichikawa T, Shimojima Y, Otuki T, Ueno KI, Kishida D, Sekijima Y.

Intern Med. 2019 Aug 6. doi: 10.2169/internalmedicine.2929-19. [Epub ahead of print]

4.

The current status of the Transthyretin Amyloidosis Outcomes Survey (THAOS) in Japan.

Sekijima Y, Mundayat R, Ishii T, Ando Y.

Amyloid. 2019;26(sup1):61-62. doi: 10.1080/13506129.2019.1583182. No abstract available.

PMID:
31343365
5.

Patient profile with ATTR-FAP and evaluation of the safety and efficacy of tafamidis meglumine in Japan - interim analysis in post-marketing surveillance.

Ishii T, Sekijima Y, Ando Y.

Amyloid. 2019;26(sup1):45-46. doi: 10.1080/13506129.2019.1582508. No abstract available.

PMID:
31343289
6.

Normal Pressure Hydrocephalus in Systemic Lupus Erythematosus: A Severe Case of Recurrent Cerebral Infarctions After Ventriculoperitoneal Shunt.

Sakaguchi N, Shimojima Y, Ushiyama S, Ichikawa T, Ikeda J, Ueno KI, Kishida D, Sekijima Y.

J Clin Rheumatol. 2019 Jun 27. doi: 10.1097/RHU.0000000000001101. [Epub ahead of print] No abstract available.

PMID:
31261312
7.

A case of cerebral amyloid angiopathy-type hereditary ATTR amyloidosis with Y69H (p.Y89H) variant displaying transient focal neurological episodes as the main symptom.

Yamada Y, Fukushima T, Kodama S, Shimizu H, Kakita A, Makino K, Sekijima Y.

Amyloid. 2019 Jul 1:1-2. doi: 10.1080/13506129.2019.1632829. [Epub ahead of print] No abstract available.

PMID:
31257920
8.

Late-onset familial Mediterranean fever in Japan.

Kishida D, Yazaki M, Nakamura A, Tsuchiya-Suzuki A, Shimojima Y, Sekijima Y.

Mod Rheumatol. 2019 Jun 25:1-4. doi: 10.1080/14397595.2019.1621440. [Epub ahead of print]

PMID:
31116049
9.

Correction to: Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.

Sekijima Y, Ueda M, Koike H, Misawa S, Ishii T, Ando Y.

Orphanet J Rare Dis. 2019 May 21;14(1):111. doi: 10.1186/s13023-019-1092-7.

10.

Length-dependent truncal Aδ-fiber dysfunction in hereditary transthyretin amyloidosis: An intra-epidermal electrical stimulation study.

Kodaira M, Ohashi N, Morita H, Sekijima Y.

Clin Neurophysiol. 2019 Jun;130(6):903-910. doi: 10.1016/j.clinph.2019.03.007. Epub 2019 Mar 23.

PMID:
30981175
11.

A novel CACNA1A nonsense variant in a patient presenting with paroxysmal exertion-induced dyskinesia.

Ogawa Y, Nakamura K, Ezawa N, Yamaguchi T, Yoshinaga T, Miyazaki D, Kosho T, Sekijima Y.

J Neurol Sci. 2019 Apr 15;399:214-216. doi: 10.1016/j.jns.2019.02.040. Epub 2019 Mar 1. No abstract available.

PMID:
30852237
12.

Muscle training-induced bilateral brachial plexopathy in an adolescent with sporadic hereditary neuropathy with liability to pressure palsies.

Kodaira M, Kodama S, Kamijo Y, Kaneko T, Sekijima Y.

Brain Behav. 2019 Feb;9(2):e01231. doi: 10.1002/brb3.1231. No abstract available.

13.

Characteristics of Circulating Natural Killer Cells and Their Interferon-γ Production in Active Adult-onset Still Disease.

Shimojima Y, Kishida D, Ueno KI, Ushiyama S, Ichikawa T, Sekijima Y.

J Rheumatol. 2019 Oct;46(10):1268-1276. doi: 10.3899/jrheum.181192. Epub 2019 Feb 15.

PMID:
30770498
14.

Role of echocardiography in assessing cardiac amyloidoses: a systematic review.

Koyama J, Minamisawa M, Sekijima Y, Kuwahara K, Katsuyama T, Maruyama K.

J Echocardiogr. 2019 Jun;17(2):64-75. doi: 10.1007/s12574-019-00420-5. Epub 2019 Feb 11.

PMID:
30741395
15.

Electrophysiological demyelinating features in hereditary ATTR amyloidosis.

Ohashi N, Kodaira M, Morita H, Sekijima Y.

Amyloid. 2019 Mar;26(1):15-23. doi: 10.1080/13506129.2018.1564903. Epub 2019 Jan 26.

PMID:
30688105
16.

Transthyretin deposition in the eye in the era of effective therapy for hereditary ATTRV30M amyloidosis.

Buxbaum JN, Brannagan T 3rd, Buades-Reinés J, Cisneros E, Conceicao I, Kyriakides T, Merlini G, Obici L, Plante-Bordeneuve V, Rousseau A, Sekijima Y, Imai A, Waddington Cruz M, Yamada M.

Amyloid. 2019 Mar;26(1):10-14. doi: 10.1080/13506129.2018.1554563. Epub 2019 Jan 24.

PMID:
30675806
17.

Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee.

Benson MD, Buxbaum JN, Eisenberg DS, Merlini G, Saraiva MJM, Sekijima Y, Sipe JD, Westermark P.

Amyloid. 2018 Dec;25(4):215-219. doi: 10.1080/13506129.2018.1549825. Epub 2019 Jan 7.

PMID:
30614283
18.

Hereditary Transthyretin Amyloidosis.

Sekijima Y.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019.
2001 Nov 5 [updated 2018 Dec 20].

19.

Presence of antibodies to striated muscle and acetylcholine receptor in association with occurrence of myasthenia gravis with myositis and myocarditis in a patient with melanoma treated with an anti-programmed death 1 antibody.

Shirai T, Kiniwa Y, Sato R, Sano T, Nakamura K, Mikoshiba Y, Ohashi N, Sekijima Y, Okuyama R.

Eur J Cancer. 2019 Jan;106:193-195. doi: 10.1016/j.ejca.2018.10.025. Epub 2018 Dec 5. No abstract available.

PMID:
30528803
20.

A controlled inflammation and a regulatory immune system are associated with more favorable prognosis of progressive multifocal leukoencephalopathy.

Sanjo N, Nose Y, Shishido-Hara Y, Mizutani S, Sekijima Y, Aizawa H, Tanizawa T, Yokota T.

J Neurol. 2019 Feb;266(2):369-377. doi: 10.1007/s00415-018-9140-0. Epub 2018 Dec 3.

PMID:
30511098
21.

Monitoring treatment response to tafamidis by serial native T1 and extracellular volume in transthyretin amyloid cardiomyopathy.

Shintani Y, Okada A, Morita Y, Hamatani Y, Amano M, Takahama H, Amaki M, Hasegawa T, Ohta-Ogo K, Kanzaki H, Ishibashi-Ueda H, Yasuda S, Shimazaki C, Yoshinaga T, Yazaki M, Sekijima Y, Izumi C.

ESC Heart Fail. 2019 Feb;6(1):232-236. doi: 10.1002/ehf2.12382. Epub 2018 Nov 27.

22.

Late-onset Transthyretin (TTR)-familial Amyloid Polyneuropathy (FAP) with a Long Disease Duration from Non-endemic Areas in Japan.

Miyake Z, Nakamagoe K, Ezawa N, Yoshinaga T, Hashimoto R, Sato T, Sekijima Y, Tamaoka A.

Intern Med. 2019 Mar 1;58(5):713-718. doi: 10.2169/internalmedicine.1457-18. Epub 2018 Oct 17.

23.

A Patient with Limbic Encephalitis Associated with Anti-leucine-rich Glioma-inactivated 1 (LGI1) Antibody Presenting with Slowly Progressive Cognitive Impairment and Fluctuating Striatal Lesions.

Sato M, Kishida D, Miyazaki D, Sekijima Y.

Intern Med. 2019 Jan 15;58(2):287-291. doi: 10.2169/internalmedicine.1082-18. Epub 2018 Aug 24.

24.

Fluctuating CSF hypocretin-1 levels in mild brain trauma-induced Kleine-Levin syndrome.

Usuda M, Kodaira M, Ogawa Y, Kanbayashi T, Yanagisawa S, Sekijima Y.

J Neurol Sci. 2018 Aug 15;391:10-11. doi: 10.1016/j.jns.2018.05.011. Epub 2018 May 17. No abstract available.

PMID:
30103953
25.

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis.

Adams D, Gonzalez-Duarte A, O'Riordan WD, Yang CC, Ueda M, Kristen AV, Tournev I, Schmidt HH, Coelho T, Berk JL, Lin KP, Vita G, Attarian S, Planté-Bordeneuve V, Mezei MM, Campistol JM, Buades J, Brannagan TH 3rd, Kim BJ, Oh J, Parman Y, Sekijima Y, Hawkins PN, Solomon SD, Polydefkis M, Dyck PJ, Gandhi PJ, Goyal S, Chen J, Strahs AL, Nochur SV, Sweetser MT, Garg PP, Vaishnaw AK, Gollob JA, Suhr OB.

N Engl J Med. 2018 Jul 5;379(1):11-21. doi: 10.1056/NEJMoa1716153.

26.

GCH1 mutations in dopa-responsive dystonia and Parkinson's disease.

Yoshino H, Nishioka K, Li Y, Oji Y, Oyama G, Hatano T, Machida Y, Shimo Y, Hayashida A, Ikeda A, Mogushi K, Shibagaki Y, Hosaka A, Iwanaga H, Fujitake J, Ohi T, Miyazaki D, Sekijima Y, Oki M, Kusaka H, Fujimoto KI, Ugawa Y, Funayama M, Hattori N.

J Neurol. 2018 Aug;265(8):1860-1870. doi: 10.1007/s00415-018-8930-8. Epub 2018 Jun 14.

PMID:
29948246
27.

Cardiac Amyloidosis Mimicking Dilated Cardiomyopathy But Showing Relative Apical Sparing of Longitudinal Strain.

Ishida M, Yamada Y, Mizutani T, Hara A, Sekijima Y, Ako J, Inomata T.

Circ J. 2018 Nov 24;82(12):3102-3103. doi: 10.1253/circj.CJ-18-0070. Epub 2018 Jun 6. No abstract available.

28.

Propylthiouracil-induced Otitis Media with Antineutrophil Cytoplasmic Antibody-associated Vasculitis.

Tanaka R, Shimojima Y, Moteki H, Kishida D, Ueno KI, Sekijima Y.

Intern Med. 2018 Oct 15;57(20):3029-3033. doi: 10.2169/internalmedicine.0944-18. Epub 2018 May 18.

29.

[Two patients with progressive multifocal leukoencephalopathy with immune response against JC virus showing good long-term outcome by combination therapy of mefloquine, mirtazapine, and risperidone].

Akagawa Y, Ueno A, Ikeda J, Ishii W, Shishido-Hara Y, Sekijima Y.

Rinsho Shinkeigaku. 2018 May 25;58(5):324-331. doi: 10.5692/clinicalneurol.cn-001166. Epub 2018 Apr 28. Japanese.

PMID:
29710027
30.

Hereditary Fibrinogen Aα-Chain Amyloidosis in Asia: Clinical and Molecular Characteristics.

Yazaki M, Yoshinaga T, Sekijima Y, Kametani F, Okumura N.

Int J Mol Sci. 2018 Jan 22;19(1). pii: E320. doi: 10.3390/ijms19010320. Review.

31.

Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.

Sekijima Y, Ueda M, Koike H, Misawa S, Ishii T, Ando Y.

Orphanet J Rare Dis. 2018 Jan 17;13(1):6. doi: 10.1186/s13023-017-0726-x. Review. Erratum in: Orphanet J Rare Dis. 2019 May 21;14(1):111.

32.

Nationwide survey on cerebrotendinous xanthomatosis in Japan.

Sekijima Y, Koyama S, Yoshinaga T, Koinuma M, Inaba Y.

J Hum Genet. 2018 Mar;63(3):271-280. doi: 10.1038/s10038-017-0389-4. Epub 2018 Jan 10.

PMID:
29321515
33.
34.

First nationwide survey on systemic wild-type ATTR amyloidosis in Japan.

Sekijima Y, Yazaki M, Ueda M, Koike H, Yamada M, Ando Y.

Amyloid. 2018 Mar;25(1):8-10. doi: 10.1080/13506129.2017.1409706. Epub 2017 Nov 28.

PMID:
29182024
35.

T-cell receptor-mediated characteristic signaling pathway of peripheral blood T cells in dermatomyositis and polymyositis.

Shimojima Y, Matsuda M, Ishii W, Kishida D, Sekijima Y.

Autoimmunity. 2017 Dec;50(8):481-490. doi: 10.1080/08916934.2017.1405942. Epub 2017 Nov 25.

PMID:
29172719
36.

One novel and two uncommon MEFV mutations in Japanese patients with familial Mediterranean fever: a clinicogenetic study.

Kishida D, Yazaki M, Nakamura A, Nomura F, Kondo T, Uehara T, Ikusaka M, Ohya A, Watanabe N, Endo R, Kawaai S, Shimojima Y, Sekijima Y.

Rheumatol Int. 2018 Jan;38(1):105-110. doi: 10.1007/s00296-017-3886-z. Epub 2017 Nov 18.

PMID:
29151129
37.

Nationwide Survey of 741 Patients with Systemic Amyloid Light-chain Amyloidosis in Japan.

Shimazaki C, Hata H, Iida S, Ueda M, Katoh N, Sekijima Y, Ikeda S, Yazaki M, Fukushima W, Ando Y.

Intern Med. 2018 Jan 15;57(2):181-187. doi: 10.2169/internalmedicine.9206-17. Epub 2017 Nov 1.

38.

A novel frameshift mutation of SYNE1 in a Japanese family with autosomal recessive cerebellar ataxia type 8.

Yoshinaga T, Nakamura K, Ishikawa M, Yamaguchi T, Takano K, Wakui K, Kosho T, Yoshida K, Fukushima Y, Sekijima Y.

Hum Genome Var. 2017 Oct 26;4:17052. doi: 10.1038/hgv.2017.52. eCollection 2017.

39.

Muscle training-induced bilateral brachial plexopathy in an adolescent with sporadic hereditary neuropathy with liability to pressure palsies.

Kodaira M, Kodama S, Kamijo Y, Kaneko T, Sekijima Y.

Brain Behav. 2017 Jul 27;7(9):e00783. doi: 10.1002/brb3.783. eCollection 2017 Sep. Erratum in: Brain Behav. 2019 Feb;9(2):e01231.

40.

Peptide probes detect misfolded transthyretin oligomers in plasma of hereditary amyloidosis patients.

Schonhoft JD, Monteiro C, Plate L, Eisele YS, Kelly JM, Boland D, Parker CG, Cravatt BF, Teruya S, Helmke S, Maurer M, Berk J, Sekijima Y, Novais M, Coelho T, Powers ET, Kelly JW.

Sci Transl Med. 2017 Sep 13;9(407). pii: eaam7621. doi: 10.1126/scitranslmed.aam7621.

41.

Visualization of multiple organ amyloid involvement in systemic amyloidosis using 11C-PiB PET imaging.

Ezawa N, Katoh N, Oguchi K, Yoshinaga T, Yazaki M, Sekijima Y.

Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):452-461. doi: 10.1007/s00259-017-3814-1. Epub 2017 Sep 10.

PMID:
28891012
42.

Increased BAFF and APRIL levels in the cerebrospinal fluid of patients with anti-neutrophil cytoplasmic antibody-related hypertrophic pachymeningitis.

Shimojima Y, Kishida D, Sekijima Y.

Cytokine. 2017 Nov;99:305-309. doi: 10.1016/j.cyto.2017.08.013. Epub 2017 Aug 25.

PMID:
28847534
43.

The Complete Remission of Acquired Immunodeficiency Syndrome-associated Isolated Central Nervous System Lymphomatoid Granulomatosis: A Case Report and Review of the Literature.

Kano Y, Kodaira M, Ushiki A, Kosaka M, Yamada M, Shingu K, Nishihara H, Hanaoka M, Sekijima Y.

Intern Med. 2017 Sep 15;56(18):2497-2501. doi: 10.2169/internalmedicine.8776-16. Epub 2017 Aug 21.

44.

Protein-losing Gastroenteropathy Related to Mixed Connective Tissue Disease: A Case Report of a Successful Outcome and Literature Review.

Kobayashi Y, Shimojima Y, Kondo Y, Takamatsu R, Miyazaki D, Kishida D, Sekijima Y, Ikeda SI.

Intern Med. 2017;56(15):2057-2062. doi: 10.2169/internalmedicine.56.8391. Epub 2017 Aug 1. Review.

45.

[DIAN/DIAN-J/DIAN-TU].

Shimada H, Shoji M, Ikeuchi T, Suzuki K, Senda M, Ishii K, Matsuda H, Iwata A, Ihara R, Iwatsubo T, Mutoh K, Nakazawa E, Sekijima Y, Mori E, Ikeda M, Ikeda M, Kawakatsu S, Nakanishi A, Hashimoto M, Nunomura A, Matsubara E, Fukui M, Shirato T, Hirai K, Sakamoto M, Fujii H, Mori H.

Brain Nerve. 2017 Jul;69(7):701-709. doi: 10.11477/mf.1416200811. Japanese.

PMID:
28739983
46.

Brain Biopsy Is More Reliable than the DNA test for JC Virus in Cerebrospinal Fluid for the Diagnosis of Progressive Multifocal Leukoencephalopathy.

Ikeda J, Matsushima A, Ishii W, Goto T, Takahashi K, Nakamichi K, Saijo M, Sekijima Y, Ikeda SI.

Intern Med. 2017;56(10):1231-1234. doi: 10.2169/internalmedicine.56.7689. Epub 2017 May 15.

47.

Pseudo-homozygous mutation due to a primer site polymorphism in hereditary ATTR amyloidosis: a pitfall of PCR-based genetic testing.

Shibata Y, Matsushima M, Yabe I, Matsuda K, Nagai A, Kano T, Yamada T, Sekijima Y, Sasaki H.

Amyloid. 2017 Mar;24(1):66-67. doi: 10.1080/13506129.2017.1307821. Epub 2017 Apr 8. No abstract available.

48.

Prevalence of Fabry disease and GLA c.196G>C variant in Japanese stroke patients.

Nagamatsu K, Sekijima Y, Nakamura K, Nakamura K, Hattori K, Ota M, Shimizu Y, Endo F, Ikeda SI.

J Hum Genet. 2017 Jul;62(7):665-670. doi: 10.1038/jhg.2017.31. Epub 2017 Mar 9.

PMID:
28275245
49.

Hypertrophic pachymeningitis is a characteristic manifestation of granulomatosis with polyangiitis: A retrospective study of anti-neutrophil cytoplasmic antibody-associated vasculitis.

Shimojima Y, Kishida D, Hineno A, Yazaki M, Sekijima Y, Ikeda SI.

Int J Rheum Dis. 2017 Apr;20(4):489-496. doi: 10.1111/1756-185X.13046. Epub 2017 Feb 20.

PMID:
28217942
50.

Postpartum Anti-N-methyl-D-aspartate Receptor Encephalitis: A Case Report and Literature Review.

Doden T, Sekijima Y, Ikeda J, Ozawa K, Ohashi N, Kodaira M, Hineno A, Tachibana N, Ikeda SI.

Intern Med. 2017;56(3):357-362. doi: 10.2169/internalmedicine.56.7442. Epub 2017 Feb 1. Review.

Supplemental Content

Loading ...
Support Center